失调
肠道菌群
阿克曼西亚
疾病
帕金森病
生物
粘蛋白
胃肠病学
微生物学
内科学
医学
细菌
免疫学
拟杆菌
生物化学
遗传学
作者
Hiroshi Nishiwaki,Mikako Ito,Tetsuya Hamaguchi,Tetsuya Maeda,Kenichi Kashihara,Yoshio Tsuboi,Jun Ueyama,Takumi Yoshida,Hiroyuki Hanada,Ichiro Takeuchi,Masahisa Katsuno,Masaaki Hirayama,Kinji Ohno
出处
期刊:npj Parkinson's disease
日期:2022-06-01
卷期号:8 (1)
被引量:21
标识
DOI:10.1038/s41531-022-00328-5
摘要
Abstract To elucidate the relevance of gut dysbiosis in Parkinson’s disease (PD) in disease progression, we made random forest models to predict the progression of PD in two years by gut microbiota in 165 PD patients. The area under the receiver operating characteristic curves (AUROCs) of gut microbiota-based models for Hoehn & Yahr (HY) stages 1 and 2 were 0.799 and 0.705, respectively. Similarly, gut microbiota predicted the progression of Movement Disorder Society-Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) III scores in an early stage of PD with AUROC = 0.728. Decreases of short-chain fatty acid-producing genera, Fusicatenibacter , Faecalibacterium , and Blautia , as well as an increase of mucin-degrading genus Akkermansia , predicted accelerated disease progression. The four genera remained unchanged in two years in PD, indicating that the taxonomic changes were not the consequences of disease progression. PD patients with marked gut dysbiosis may thus be destined to progress faster than those without gut dysbiosis.
科研通智能强力驱动
Strongly Powered by AbleSci AI